ing and might be related to the presence of associated vital structures, which include the facial nerve, parotid gland, and the close proximity to the cranial base. Herein we present a case of a large chondrosarcoma in the TMJ area.
After surgery, the patient experienced anesthesia in the temporal, buccal, and zygomatic branch regions and hypoesthesia in the mandibular and cervical branch. The motor nerve was also damaged; thus, movement of the right side of the forehead and corner of the mouth was barely detectable, but she could close her right eye, although this occurred much slower compared to the left eye.
Microscopic examination of sections stained with H&E revealed chondrocytes with irregular nuclei. Heterogeneous tumor cells embedded in the chondrocyte lacuna in the mucinous or chondroid stroma were also observed. The cells were composed of a diffuse proliferation of atypical chondrocytic cells in a myxoid or chondroid matrix where granular calcified materials were scattered and showed cellular pleomorphism with a bizarre nucleus appearance. Mitosis was observed in some areas. (Fig. 3 . B, 3. C) Histological diagnosis was a low grade (grade I) chondrosarcoma without perineural, vascular, or lymph node invasion.
Due to the large size of the tumor, it was difficult to obtain sufficient marginal clearance. The patient was referred to a radiation oncologist for adjunctive radiation therapy mor cells with cellular polymorphism were embedded in the chondrocyte lacuna in the mucinous or chondroid stroma. Based on the above findings, a diagnosis of grade 1 chondrosarcoma was made.
Surgical treatment was planned; due to the large mass involving the condyle, glenoid fossa, and cranial base with adjacent tissues, an extraoral approach with an extended preauricular incision, combined with a submandibular incision was used. The mass was dissected and surgically resected from adjacent perilesional tissue in a single block, and portions of the facial nerve involved in the mass were sacrificed. During surgery, for functional reconstruction of the facial nerve, the great auricular nerve was grafted to the damaged facial nerve. The auricular nerve graft was intentionally cut and ligated to both ends of the damaged facial nerve under microscopy. Part of the cranial bone base was also resected; fortunately, there was no invasion of the dura. (Fig. 2) The excised mass measured 8.5×6.5 cm in size with an intact synovial membrane and disk, and there appeared to be glistening cartilaginous tissue with a grayish-white pattern on the cut surface. (Fig. 3 
III. Discussion
Chondrosarcoma is a malignant tumor that originates in cartilaginous cells and that remains malignant throughout its evolution. Chondrosarcoma represents 10% to 20% of all malignant bone tumors, and only 1% to 12% originate in the head and neck region 3, 4 . The most common site in the head and neck is the larynx, followed by the mandible, nasal cavity, and maxilla 5 . Chondrosarcoma in the TMJ area is rare, with only 30 cases reported in the literature ; all are presented in Table 1 .
In previous reports, the mean age of patients with chondrosarcoma in the TMJ area was 38 to 48 years with no or slight female sex predominance. These characteristics vary from chondrosarcomas that occur in the head and neck area 15, 33 . A major symptom of chondrosarcoma in the TMJ area is swelling in the preauricular region, followed by pain and trismus 5 . The duration of symptoms before final diagnosis is generally 3 to 24 months 17 , although several studies have reported a duration of 6 to 8 years 23 . For accurate diagnosis, conventional radiographic investigation and computed tomography are helpful, but there are no unique pathognomonic findings in chondrosarcoma 34 , which appears as a mass with single or multiple radiolucent areas that can involve a calcified mass with a condylar deformity, bone destruction, erosion of adjacent bone, condylar resorption, and sometimes cranial invasion. In most cases, increases due to the close margin. The radiation was delivered in a daily single dose of 1.8 Gy, total dose of 50.4 Gy on the right parapharyngeal space and a total dose of 10.8 Gy on the right infratemporal fossa area. After radiation therapy, radiographic and clinical examinations during the follow-up period showed no signs of recurrence. The patient is a young woman, and esthetic outcomes were very important for her. She desired reconstructive surgery to address the soft tissue defect in the right preauricular area as early as possible. (Fig.  4) Subsequently, reconstruction was performed with a fibular osteocutaneous free flap 8 months after the first surgery. The condyle was reconstructed with fibular bone, and the soft tissue depression in the preauricular area was augmented with a 
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year rate is 28% 32 . Murayama et al. 15 reported that 8 of 20 patients died 5 months to 6 years after primary treatment. Although Evans et al. 36 reported that the pathological grade was a useful prognostic factor, Saito et al. 33 reported that grade was not related to prognosis. Conversely, metastasis is related to histological grade; in grade II, the reported metastasis rate is 10%, while that in grade III is 71%. There were no reports of metastasis in grade I chondrosarcoma. Local recurrence is more common than distant metastasis and is related to tumor grade. Metastasis usually occurs in limbs and lungs, and regional lymph node metastasis is uncommon 20 . However, the most important factor in prognosis is resectability.
Wide local resection is the first choice of treatment, and neck node dissection is usually unnecessary because of the low incidence of regional lymph node metastasis 37 . Chondrosarcoma is traditionally regarded as radioresistant, and radiation therapy is best reserved for high-grade lesions. However, a recent study reported that it can be radiosensitive and potentially radiocurable. However, radiation therapy is generally used as an adjunct treatment and not as a single in the articular space and the length of the condylar neck with radiopacity of the condyle are observed 5 . In many chondrosarcomas of the TMJ, radiographic evidence of widening of the joint space has been reported 35 . In this case report, joint space widening was also observed in computed tomography.
Histopathologically, chondrosarcoma of the TMJ area is similar to that of the head and neck areas or pelvis, ribs, or other regions. The lesions are microscopically lobulated with cellular neoplasms, hyaline cartilaginous proliferation, and sarcomatous stroma that contain stellate. The presence of mitotic figures is rare; therefore, their absence cannot rule out the diagnosis of chondrosarcoma. Criteria for diagnosis include an increase in the number of cells, expansion of cells, and formation of giant or binucleated cells 3 . Chondrosarcoma is classified into grade I, II, or III based on the frequency of mitosis, cellularity, and nucleus size 36 . However, distinguishing the grade is difficult because the grading system is derived from other joint chondrosarcomas, not solely from temporomandibular area chondrosarcomas 20 . The reported 5-year survival rate is 44% to 54.6%, and 10- Lanier et al. 7 Sudo et al. 8 Richter et al. 9 Tullio and D'Errico 10 Kato et al. 11 Kato et al. 11 Nortjé et al. 12 Cadenat et al. 13 Morris et al. 14 Murayama et al. 15 Wasenko and Rosenbloom 16 Nitzan et al. 17 Merrill et al. 18 Giraud et al. 19 Sesenna et al. 20 Ichikawa et al. 21 Batra et al. 22 Mostafapour and Futran 23 Mostafapour and Futran 23 Angiero et al. 24 Yun et al. 25 Oliveira et al. 26 Gallego et al. 5 Garzino-Demo et al. 27 González-Pérez et al. 28 Ramos-Murguialday et al. 29 Abu-Serriah et al. 30 Giorgione et al. 31 MacIntosh et al. 32 Our case   1954  1971  1972  1974  1974  1975  1975  1976  1979  1987  1988  1990  1993  1997  1997  1997  1998  1999  2000  2000  2007  2008  2009  2009  2010  2011  2012  2013  2015  2015  2016   46  48  ND  75  17  ND  ND  40  60  29  30  49  36  50  ND  60  66  65  31  52  64  29  11  54  65  57  45  48  56  31 47 . In other reports, the tumor size was usually less than 3.0 to 4.0 cm. One case reported a 5.0-cm sized mass that was reconstructed with a rectus free flap 35 . In our case, the lesion size was 8.5 cm, which is exceptionally large for oral and maxillofacial surgery, making it difficult to obtain appropriate marginal clearance. Resection resulted in a large defect on the face and associated esthetic and functional problems. Therefore, radiation therapy and reconstructive surgery were required.
In our case, an enlarging mass and widening of the joint space in computed tomography were helpful to diagnose the chondrosarcoma before open biopsy. Wide local resection was attempted, with facial nerve sacrifice, but it was difficult to obtain a clear margin due to the large-sized mass; adjunctive radiation therapy was performed, and there was no sign of recurrence after follow-up for 8 months. Because of the large mandible defect of the condyle, glenoid fossa, and soft tissue in the right preauricular area, we used a fibular osteocutaneous free flap to reconstruct the mandible. This flap has relatively low donor morbidity and provided a good esthetic outcome.
In conclusion, chondrosarcoma of the TMJ is a very rare event. In our patient, because of the large mass, which was related to glenoid fossa involvement, the cranial base, facial nerve, and condyle were also involved. Using an extraoral approach, the mass was dissected and resected in a single block, and the sacrificed facial nerve was repaired with a nerve graft. Reconstructive surgery was performed following radiation therapy, 8 months after the first surgery, using a fibular osteocutaneous free flap for optimal functional and esthetic results. The long-term prognosis and recovery of the facial nerve function will be reported in future work.
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